Alpa Laboratories Ltd. | Small-cap | Healthcare
₹103.68
0.06%
| Alpa Laboratories Stock Comparison:
Alpa Laboratories vs Sun PharmaceuticalAlpa Laboratories vs Divi's LaboratoriesAlpa Laboratories vs Aarti DrugsAlpa Laboratories vs Sequent ScientificAlpa Laboratories vs Unichem LaboratoriesAlpa Laboratories vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 399.2M
Gross Profit 107.6M 26.95%
Operating Income -3.8M -0.94%
Net Income -21.7M -5.45%

Balance Sheet Metrics

Total Assets 2.2B
Total Liabilities 511.6M
Shareholders Equity 1.7B
Debt to Equity 0.30

Cash Flow Metrics

Revenue & Profitability Trend

Alpa Laboratories Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.1B1.1B924.1M1.1B964.1M
Cost of Goods Sold i764.6M746.0M615.0M760.9M647.6M
Gross Profit i359.9M333.1M309.1M344.3M316.6M
Gross Margin % i32.0%30.9%33.5%31.2%32.8%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-75.2M62.6M75.2M66.9M
Other Operating Expenses i168.5M35.4M42.7M54.5M33.4M
Total Operating Expenses i168.5M110.6M105.3M129.6M100.3M
Operating Income i25.5M77.3M73.4M95.4M97.2M
Operating Margin % i2.3%7.2%7.9%8.6%10.1%
Non-Operating Items
Interest Income i-23.2M10.4M14.6M6.5M
Interest Expense i2.3M3.2M825.0K1.1M261.0K
Other Non-Operating Income-----
Pre-tax Income i256.7M206.8M158.9M195.6M107.9M
Income Tax i61.6M39.1M33.1M54.7M35.4M
Effective Tax Rate % i24.0%18.9%20.8%28.0%32.8%
Net Income i195.0M167.8M125.8M140.9M72.5M
Net Margin % i17.3%15.5%13.6%12.8%7.5%
Key Metrics
EBITDA i281.0M143.3M146.2M130.3M112.5M
EPS (Basic) i-₹8.01₹5.88₹6.70₹3.45
EPS (Diluted) i-₹8.01₹5.88₹6.70₹3.45
Basic Shares Outstanding i-21040600210406002104060021041000
Diluted Shares Outstanding i-21040600210406002104060021041000

Income Statement Trend

Alpa Laboratories Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i265.0K17.1M88.1M15.8M18.0M
Short-term Investments i1.1B911.4M720.3M687.0M406.9M
Accounts Receivable i468.3M411.5M467.3M380.4M354.3M
Inventory i176.4M136.7M126.4M154.6M165.6M
Other Current Assets89.2M667.0K81.6M72.7M107.8M
Total Current Assets i1.9B1.6B1.5B1.4B1.2B
Non-Current Assets
Property, Plant & Equipment i206.0M58.6M58.3M58.2M58.2M
Goodwill i483.0K601.0K834.0K2.1M1.1M
Intangible Assets i-601.0K834.0K1.0M551.0K
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i314.1M213.9M173.9M172.3M192.8M
Total Assets i2.2B1.8B1.6B1.6B1.4B
Liabilities
Current Liabilities
Accounts Payable i186.9M117.8M150.6M149.2M247.3M
Short-term Debt i-52.5M15.3M37.2M1.8M
Current Portion of Long-term Debt-----
Other Current Liabilities213.6M78.3M22.8M25.7M2.8M
Total Current Liabilities i466.7M280.7M296.3M313.8M327.2M
Non-Current Liabilities
Long-term Debt i007.8M21.2M91.0K
Deferred Tax Liabilities i44.9M24.0M22.8M25.7M2.2M
Other Non-Current Liabilities--1.0K1.0K-2.0K1.0K
Total Non-Current Liabilities i44.9M24.0M30.6M21.2M92.0K
Total Liabilities i511.6M304.6M326.9M335.1M327.3M
Equity
Common Stock i210.4M210.4M210.4M210.4M210.4M
Retained Earnings i-759.1M585.8M457.3M316.4M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.7B1.5B1.3B1.2B1.1B
Key Metrics
Total Debt i052.5M23.0M58.5M1.9M
Working Capital i1.4B1.3B1.2B1.1B883.7M

Balance Sheet Composition

Alpa Laboratories Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i258.2M207.6M156.8M195.6M107.9M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-121.9M42.3M-38.2M86.8M-225.2M
Operating Cash Flow i11.7M235.1M110.4M270.0M-123.0M
Investing Activities
Capital Expenditures i-113.8M-63.9M-11.3M-21.9M-28.5M
Acquisitions i112.6M0-5.0M42.3M0
Investment Purchases i-33.9M-95.1M-286.0K-191.8M-
Investment Sales i----79.1M
Investing Cash Flow i-35.1M-159.0M9.0M-171.4M50.7M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i----4.5M
Debt Repayment i---263.0K--1.8M
Financing Cash Flow i-52.5M37.2M-525.0K58.5M5.2M
Free Cash Flow i-43.2M-27.4M77.8M77.5M-49.2M
Net Change in Cash i-75.9M113.3M118.9M157.1M-67.1M

Cash Flow Trend

Alpa Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 11.10
Forward P/E 19.60
Price to Book 1.35
Price to Sales 1.94
PEG Ratio 19.60

Profitability Ratios

Profit Margin 17.34%
Operating Margin -0.96%
Return on Equity 12.06%
Return on Assets 0.79%

Financial Health

Current Ratio 4.10
Debt to Equity 0.00
Beta 0.69

Per Share Data

EPS (TTM) ₹9.34
Book Value per Share ₹76.66
Revenue per Share ₹53.85

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
alpa2.2B11.101.3512.06%17.34%0.00
Sun Pharmaceutical 4.1T37.175.6315.71%20.79%3.26
Divi's Laboratories 1.8T81.3011.9415.35%23.41%0.03
Aarti Drugs 47.8B25.393.4912.68%7.05%44.92
Sequent Scientific 46.9B221.006.664.35%1.41%62.47
Unichem Laboratories 44.2B32.261.805.72%6.52%18.76

Financial data is updated regularly. All figures are in the company's reporting currency.